Late-breaking oral presentation will show early findings from Phase I PLAT-08 study of SC-DARIC33, an investigational, potentially first-in-class CD33-targeting CAR T in pediatric and young adults with relapsed/refractory acute myeloid leukemia (AML) Updates on the Company’s portfolio include investigational therapies in AML, non-Hodgkin lymphoma (NHL) and solid tumors CAMBRIDGE, Mass.–(BUSINESS WIRE)–2seventy bio, Inc. (Nasdaq: TSVT), … [Read more…]

Both leading independent proxy advisors recommend shareholders vote for the re-election of incumbent directors, equity incentive plan amendment, and appointment of auditors Company reminds shareholders to vote today to protect the value of their investment and ensure Aurinia’s continued momentum Company to release first quarter financial and operational results on May 4, 2023 Shareholders with … [Read more…]

Preclinical data demonstrate iGPS particles efficiently and specifically deliver CAR molecules to T cells in vivo for durable tumor clearance without need for lymphodepleting chemotherapy Company developing iGPS technology to provide potentially safe, efficacious, manufacturable, and widely accessible “off-the-shelf” in vivo CAR T therapies; discloses multiple myeloma as lead program Company to share additional preclinical … [Read more…]

ST. PAUL, Minn.–(BUSINESS WIRE)–Christophe Beck, Ecolab Inc. chairman and chief executive officer, will address financial analysts at the Barclays Americas Select Franchise Conference on Tuesday, May 9. Ecolab will offer a webcast of Mr. Beck’s presentation. Details for the webcast are as follows: TIME:         8:30 a.m. Eastern Time       … [Read more…]

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that it plans to report its financial results for its fiscal second quarter ended March 31, 2023 after the U.S. market closes on May 8, 2023. Enanta management will host a conference call … [Read more…]

Webcast to be held Tuesday, May 9, 4:30 p.m. ET, register here, or at the link below. DALLAS–(BUSINESS WIRE)–$LTRN–Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that … [Read more…]

Worldwide revenue of $93.5 million – an increase of 25.4% year over year U.S. revenue of $78.2 million – an increase of 25.6% year over year International revenue of $15.3 million – an increase of 24.4% year over year Net loss of $6.5 million – an improvement of $8.7 million year over year Positive adjusted … [Read more…]

– Conference Call and Webcast Today, May 2, 2023 at 4:30 p.m. ET PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30 p.m. ET to discuss the results. Webcast and Conference … [Read more…]

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today the closing of its previously announced underwritten public offering of 4,312,500 shares of its common stock and warrants to purchase 2,156,250 shares of its common stock, which included the exercise in … [Read more…]

NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Northwell Health’s Senior Vice President for the Katz Institute of Women’s Health, Stacey E. Rosen, MD, has been awarded the prestigious Wenger Award for Excellence in Medical Advocacy from WomenHeart: The National Coalition for Women with Heart Disease. The award recognizes Dr. Rosen’s significant contributions to the field of women’s heart … [Read more…]